Author: Julio Gonzalez-Lopez (Spain)
Co-authors: Nicolás Echeverría, Álvaro Martín Ares, Esther Ciancas
Purpose
To describe epidemiological characteristics of patients with uveitis requiring small-gauge vitreoretinal surgery, the reasons for vitreoretinal surgery, and the outcome of these patients.
Setting/Venue
Single, tertiary-care, university-affiliated hospital in Madrid, Spain.
Methods
A retrospective, non-comparative cohort study was performed. All patients undergoing small-gauge vitrectomy between October 2018 and October 2020, including those in which vitrectomy was combined with other procedures like phacoemulsification, with a previous diagnosis of infectious or noninfectious uveitis were included. Only one eye per patient was included in the study. In those patient who had vitrectomy in both eyes during the study period, only the first eye was included in the analysis. Epidemiological, clinical and surgical data were retrieved from the electronic clinical records by 2 of the authors.
Results
Thirteen patients with uveitis required vitrectomy during the 2 year period. This represents 2% of the patients with uveitis who attended our uveitis clinic within that period. Median age was 55 years (range 22 to 86). Six were women (46.1%). Nine patients had a diagnosis of infectious uveitis (4 acute retinal necrosis secondary to VZV, 2 endogenous ocular candidiasis, 2 CMV-related uveitis and 1 ocular toxoplasmosis). Four cases were non-infectious uveitis (2 multiple sclerosis-related intermediate uveitis, 1 intermediate uveitis in B27+ psoriatic arthropathy and 1 idiopathic anterior uveitis). Reasons for vitrectomy were floaterectomy for vitreous debris in 7 patients (53.8%), regmathogenous retinal detachment secondary to acute retinal necrosis in 2 (15.4%), endophotocoagulation in acute retinal necrosis in 2 (15.4%), malignant glaucoma in 1 (7.7%), ERM peel in 1 (7.7%). Combined phacoemulsification and vitrectomy surgery was performed in 5 cases (38.5%). Median best corrected visual acuity (BCVA) changed from 1.0 LogMAR preop (range 0.3 to 2.7) to 0.5 LogMAR at discharge (range 0,0 to 2,7; Wilcoxon p=0.018). BCVA improved after surgery in 7 cases (53.8%), and remained stable in 6 (46.2%). Uveitis recurred in 4 patients. Median time to recurrence was 442 days (range 314 to 867 days).
Conlusions
One in fifty patients with uveitis may require vitreoretinal surgery. Infectious uveitis, specially viral retinitis and ocular candidiasis are more likely to require vitreoretinal surgery. BCVA improved in after surgery in approximately half of the cases. Vitrectomy did not appear to increase the risk of flare-up during the early postoperative period.
Financial Disclosure
The authors declare no potential conflicts of interests relevant to this abstact.
Comments
-